Marganakop, Sheetal B.; Kamble, Ravindra R.; Sannaikar, Madivalagouda S.; Bayannavar, Praveen K.; Kumar, S. Madan; Inamdar, Sanjeev R.; Shirahatti, Arunkumar M.; Desai, Saleem M.; Joshi, Shrinivas D. published the artcile< SCXRD, DFT and molecular docking based structural analyses towards novel 3-piperazin-1-yl-benzo[d]isothiazole and 3-piperidin-4-yl-benzo[d]isoxazoles appended to quinoline as pharmacological agents>, Safety of 6-Fluoro-3-(4-piperidinyl)-1,2-benzisoxazole, the main research area is quinoline piperazinyl benzoisothiazole benzoisoxazole preparation antibacterial antifungal DFT; bromomethyl chloroquinoline benzothiazole benzoxazole nucleophilic substitution reaction.
Novel quinoline containing 3-piperazin-1-yl-benzo[d]isothiazoles and 3-piperidin-4-yl-benzo[d]isoxazole were synthesized. Hirshfeld surface, electrostatic potential maps were obtained resp. from SCXRD and DFT studies. These compounds were analyzed for in vitro antimicrobial activity and correlated with energy difference (ΔE) between HOMO and LUMO energy levels obtained from DFT and correlated with ΔE of standard drug to explain the activity. Further the antimicrobial activity was corroborated by docking against various target enzymes. The present work provided some hints for developing novel antimicrobial quinoline derivatives
Journal of Molecular Structure published new progress about Antibacterial agents. 84163-77-9 belongs to class benzisoxazole, and the molecular formula is C12H13FN2O, Safety of 6-Fluoro-3-(4-piperidinyl)-1,2-benzisoxazole.
Referemce:
Benzisoxazole – Wikipedia,
Benzisoxazole – an overview | ScienceDirect Topics